Impact of Recombinant VSV-HIV Prime, DNA-Boost Vaccine Candidates on Immunogenicity and Viremia on SHIV-Infected Rhesus Macaques.

MLA

Berger, Alice, et al. “Impact of Recombinant VSV-HIV Prime, DNA-Boost Vaccine Candidates on Immunogenicity and Viremia on SHIV-Infected Rhesus Macaques.” Vaccines, vol. 12, no. 4, Apr. 2024, p. 369. EBSCOhost, https://doi.org/10.3390/vaccines12040369.

APA

Berger, A., Pedersen, J., Kowatsch, M. M., Scholte, F., Lafrance, M.-A., Azizi, H., Li, Y., Gomez, A., Wade, M., Fausther-Bovendo, H., de La Vega, M.-A., Jelinski, J., Babuadze, G., Nepveu-Traversy, M.-E., Lamarre, C., Racine, T., Kang, C.-Y., Gaillet, B., Garnier, A., & Gilbert, R. (2024). Impact of Recombinant VSV-HIV Prime, DNA-Boost Vaccine Candidates on Immunogenicity and Viremia on SHIV-Infected Rhesus Macaques. Vaccines, 12(4), 369. https://doi.org/10.3390/vaccines12040369

Chicago

Berger, Alice, Jannie Pedersen, Monika M. Kowatsch, Florine Scholte, Marc-Alexandre Lafrance, Hiva Azizi, Yue Li, et al. 2024. “Impact of Recombinant VSV-HIV Prime, DNA-Boost Vaccine Candidates on Immunogenicity and Viremia on SHIV-Infected Rhesus Macaques.” Vaccines 12 (4): 369. doi:10.3390/vaccines12040369.